ReliaQuest Expands GreyMatter Platform With Support For Risk Scenarios and Mitre Att&ck V10
Many leaders are challenged with measuring the progress of their security program and the impact of their security investments. According to a recent Ponemon Institute Research report, 64% of security leaders say a lack of standardized security metrics to measure progress is the primary obstacle to implementing an IT security risk management program. What's more, 58% say that the lack of a well-defined security and risk management program is what makes their organization most vulnerable to cyberattacks.
With the ability to map coverage against Risk Scenarios, GreyMatter enables security leaders to have a real-time view into how they are performing against individual threats or cyber risks they are most concerned about. They can pinpoint any gaps in coverage and make informed decisions on how best to proceed with investments and actions to close these gaps. Breakdowns by cyber risk categories and subcategories within them help security leaders focus on areas of concern at a granular level.
"Too often, leaders rely on technical metrics that lack a holistic view of how security tools are operating together, leaving them at a loss when it comes to communicating cyber risks to the business," said Brian Foster, Chief Product Officer at ReliaQuest. "What's more, translating the effectiveness of security tools in a language that leadership understands poses even more of a challenge. Now, with Risk Scenarios, security leaders have a more comprehensive view into how much coverage they have across cyber risk areas that concern them the most. This will help them make informed decisions on how best to approach these issues and communicate them effectively to leadership."
Additionally, ReliaQuest announced an upgrade of its support for the latest MITRE ATT&CK framework version 10. By upgrading to support v10 of the framework, GreyMatter (https://www.reliaquest.com/
To learn more about ReliaQuest GreyMatter, please visit www.reliaquest.com.